SCHEMBL17878552

SCHEMBL17878552

CCCC(CCC)OC(=O)CCC(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
MAPK1 P28482 3/20 0.44
LMNA P02545 4/20 0.42
ALDH1A1 P00352 2/20 0.42
CA1 P00915 2/20 0.41
PRKCA P17252 1/20 0.39
PRKCE Q02156 1/20 0.39
PRKCQ Q04759 1/20 0.39
PRKCD Q05655 1/20 0.39
CTSK P43235 1/20 0.38
CYP1A2 P05177 3/20 0.37
MEN1 O00255 1/20 0.36
GMNN O75496 1/20 0.36
HSP90AA1 P07900 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
FAAH O00519 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17878539 0.92 MAPT (0.42) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL17882029 0.85 ALDH1A1 (0.50) MAPTMAPK1LMNAALDH1A1PRKCA
SCHEMBL30547122 0.83 LMNA (0.42) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL17878538 0.83 LMNA (0.42) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL14013022 0.82 MAPT (0.43) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL17943122 0.81 MAPK1 (0.66) MAPTMAPK1LMNAALDH1A1PRKCA
SCHEMBL2988078 0.81 CA1 (0.43) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL4735807 0.81 CA1 (0.43) MAPTMAPK1LMNAALDH1A1CA1
SCHEMBL22534417 0.81 MAPT (0.60) MAPTMAPK1LMNAALDH1A1PRKCA
SCHEMBL2978623 0.81 CA1 (0.43) MAPTMAPK1LMNAALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 MAPT 4274/4885MAPK1 1910/4885LMNA 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.